Long-term Cardiovascular Risks of Gonadotropin-releasing Hormone Agonists and Antagonists: A Population-based Cohort Study
Clinical Oncology · 2023
DOI: 10.1016/j.clon.2023.03.014 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Oncology, 2023. Verfasst von J S K Chan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cardio-oncology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Myocardial Infarction, Prostatic Neoplasms, Stroke. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Hong Kong Metropolitan University, National Cancer Institute.
Abstract (Originalsprache)
AIMS: Gonadotropin-releasing hormone (GnRH) agonists and antagonists, critical medications for prostate cancer (PCa) treatment, may differ in cardiovascular safety. This prospective cohort study aimed to compare the long-term cardiovascular risks between GnRH agonists and antagonists. MATERIALS AND METHODS: Patients with PCa receiving GnRH agonists or antagonists during 2013-2021 in Hong Kong were identified. Patients with
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardio-oncology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.
- Cardio-oncology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China; Division of Urology, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, C…
- Division of Urology, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK.
- Cardio-oncology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China; Kent and Medway Medical School, Canterbury, UK; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascul…
Förderung
- Hong Kong Metropolitan University
- National Cancer Institute
Zitieren
APA
Chan, J. S. K., Lee, Y. H. A., Hui, J. M. H., Liu, K., Dee, E. C., Ng, K., Tang, P., Tse, G., & Ng, C. F. (2023). Long-term Cardiovascular Risks of Gonadotropin-releasing Hormone Agonists and Antagonists: A Population-based Cohort Study. Clinical Oncology. https://doi.org/10.1016/j.clon.2023.03.014
Vancouver
Chan JSK, Lee YHA, Hui JMH, Liu K, Dee EC, Ng K, et al. Long-term Cardiovascular Risks of Gonadotropin-releasing Hormone Agonists and Antagonists: A Population-based Cohort Study. Clinical Oncology. 2023. doi:10.1016/j.clon.2023.03.014
BibTeX
@article{Chan2023,
author = {Chan, J S K and Lee, Y H A and Hui, J M H and Liu, K and Dee, E C and Ng, K and Tang, P and Tse, G and Ng, C F},
title = {Long-term Cardiovascular Risks of Gonadotropin-releasing Hormone Agonists and Antagonists: A Population-based Cohort Study},
journal = {Clinical Oncology},
year = {2023},
doi = {10.1016/j.clon.2023.03.014}
}
EUVIMED